Sawai Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4555
JP3323050009
Pharmaceuticals
Sales 2024 * | 194B 1.24B | Sales 2025 * | 203B 1.3B | Capitalization | 254B 1.63B |
---|---|---|---|---|---|
Net income 2024 * | 19.79B 127M | Net income 2025 * | 19.91B 128M | EV / Sales 2024 * | 1.49 x |
Net Debt 2024 * | 34.69B 223M | Net Debt 2025 * | 39.72B 255M | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
12.7
x | Employees | 3,393 |
Yield 2024 * |
2.24% | Yield 2025 * |
2.37% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
President | 66 | 21-03-31 | |
Toru Terashima
BRD | Director/Board Member | 64 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 21-03-31 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |